Aquestive Therapeutics, Inc. (AQST) Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film Transcript [Seeking Alpha]
Aquestive Therapeutics, Inc. (AQST)
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.aquestive.com/investor-relations
Company Research
Source: Seeking Alpha
Company Participants Daniel Barber - CEO, President & Director Sherry Korczynski - Chief Commercial Officer Gary Slatko - Interim Chief Medical Officer Melina Cioffi - Senior Vice President of Regulatory Affairs Matthew Davis - Chief Development Officer Conference Call Participants Roanna Clarissa Ruiz - Leerink Partners LLC, Research Division Kristen Kluska - Cantor Fitzgerald & Co., Research Division David Amsellem - Piper Sandler & Co., Research Division Andreas Argyrides - Oppenheimer & Co. Inc., Research Division Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division François Brisebois - LifeSci Capital, LLC, Research Division Thomas Flaten - Lake Street Capital Markets, LLC, Research Division Jason Butler - Citizens JMP Securities, LLC, Research Division Laura Suriel Presentation Operator Good day and thank you for standing by. Welcome to the Aquestive Therapeutics conference call. [Operator Instructions] I will now hand the conf
Show less
Read more
Impact Snapshot
Event Time:
AQST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AQST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AQST alerts
High impacting Aquestive Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AQST
News
- Aquestive Therapeutics, Inc. (NASDAQ:AQST) Analysts Just Trimmed Their Revenue Forecasts By 26% [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive TherapeuticsGlobeNewswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQSTGlobeNewswire
- Leerink sees ‘silver lining' in Aquestive CRL given defined path to approval [Yahoo! Finance]Yahoo! Finance
- Aquestive Therapeutics (NASDAQ:AQST) was given a new $6.00 price target on by analysts at Lake Street Capital.MarketBeat
AQST
Earnings
- 11/5/25 - Miss
AQST
Sec Filings
- 2/2/26 - Form 8-K
- 1/21/26 - Form S-8
- 1/9/26 - Form 8-K
- AQST's page on the SEC website